Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, Léon, Jung, Grace, Valore, Erika V, Rivella, Stefano, Nemeth, Elizabeta, Ganz, Tomas·2014·Nature Genetics
DOI 10.1038/ng.2996

Cited by (1,000)

Items 701–800 of 1,000

  1. Regulators impeding erythropoiesis following iron supplementation in a clinically relevant rat model of iron deficiency anemia with inflammation
    Sung Yeon Ham, Ji Hae Jun, Hye-Bin Kim, Jae‐Kwang Shim, Gisong Lee, Young Lan Kwak · 2022 · Life Sciences
  2. Impact of conditioning and engraftment on iron status in hematopoietic stem cell transplantation
    Flávio Augusto Naoum, Breno Pannia Espósito, Rodolfo Delfini Cançado · 2016 · Hematology/Oncology and Stem Cell Therapy
  3. Influence of Hepcidin in the Development of Anemia
    Cadiele Oliana Reichert, Filomena Marafon, Débora Levy, Luciana Morganti Ferreira Maselli, Margarete Dulce Bagatini, Solange Lúcia Blatt, Sérgio Paulo Bydlowski, Celso Spada · 2018 · InTech eBooks
  4. Erythroferrone: A Missing Link in Iron Regulation
    Mark J. Koury · 2015 · The Hematologist
  5. Iron kinetics and laboratory assessment
    Kathryn Doig · 2020 · Elsevier eBooks
  6. Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation
    Maria Feola, Andrea Zamperone, Daniel R Moskop, Huiyong Chen, Carla Casu, Dechen Lama, Julie S. Di Martino, Mansour Djedaini, Luena Papa, Marc Ruíz-Martínez et al. · 2021 · Communications Biology
  7. Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
    Filomena Longo, Antonio Giulio Piga · 2022 · Journal of Clinical Medicine
  8. Hepatic erythropoietin response in cirrhosis. A contemporary review
    Louise Madeleine Risør, Mogens Fenger, Niels Vidiendal Olsen, Søren Møller · 2016 · Scandinavian Journal of Clinical and Laboratory Investigation
  9. Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin
    Juliana Miguel Bilar, Patrícia da Silva Fucuta Pereira, Ana Cristina Amaral, Roberto José de Carvalho‐Filho, Ivonete Silva, Jose Osmar Medina-Pestana, Maria Lúcia Gomes Ferraz · 2020 · Transplantation Proceedings
  10. Polycythemia vera: the current status of preclinical models and therapeutic targets
    Niccolò Bartalucci, Paola Guglielmelli, Alessandro Maria Vannucchi · 2020 · Expert Opinion on Therapeutic Targets
  11. The changing landscape of iron overload disorders at the beginning of the 21st century
    Guy Rostoker · 2017 · La Presse Médicale
  12. Development of rat and mouse models of heme-iron absorption
    Jennifer K. Lee, Yue He, Shireen RL Flores, Regina R. Woloshun, Xiaoyu Wang, Jacob S. Shine, Pearl Onuwa Ebea, Sitara Sriram, Melissa Fraga, Sean Zhu et al. · 2025 · JCI Insight
  13. The Gut Microbial Metabolite Indole-3-Acetic Acid Reprograms Systemic Homeostasis and Ameliorates IBD-Associated Cachexia Independent of Food Intake
    Ayame Tomii, Chihiro Takei, Keisuke Yoshikiyo, Hidehisa Shimizu · 2025 · International Journal of Molecular Sciences
  14. Anemia in Pregnancy With CKD
    Margriet F. C. de Jong, Elizabeta Nemeth, Pien Rawee, Kate Bramham, Michele Freerk Eisenga · 2024 · Kidney International Reports
  15. Key Genes FECH and ALAS2 under Acute High-Altitude Exposure: A Gene Expression and Network Analysis Based on Expression Profile Data
    Yifan Zhao, Lingling Zhu, Dawei Shi, Jiayue Gao, Ming Fan · 2024 · Genes
  16. Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?
    Francesco Locatelli, Lucia Del Vecchio · 2017 · Journal of Nephrology
  17. Can molecular markers of oxygen homeostasis and the measurement of tissue oxygen be leveraged to optimize red blood cell transfusions?
    Jin Hyen Baek, Paul W. Buehler · 2019 · Current Opinion in Hematology
  18. A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels
    Acaynne Lira Zidanes, Giacomo Marchi, Fabiana Busti, Alessandro Marchetto, Elisa Fermo, Alejandro Giorgetti, Alice Vianello, Annalisa Castagna, Oliviero Olivieri, Paola Ilaria Bianchi et al. · 2020 · Frontiers in Physiology
  19. Characterization of Erythroferrone in a Teleost Fish (Dicentrarchus labrax) With Two Functional Hepcidin Types: More Than an Erythroid Regulator
    João Vilares Neves, Carolina Barroso, Pedro Carvalho, Magda Nunes, Giovani Sampaio Gonçalves, Pedro Rodrigues · 2022 · Frontiers in Immunology
  20. Developmental changes in iron metabolism and erythropoiesis in mice with human gain‐of‐function erythropoietin receptor
    Barbora Králová, Lucie Sochorcova, Jihyun Song, Ondřej Jahoda, Katarina Kapralova, Josef T. Prchal, Vladimír Divoký, Monika Horváthová · 2022 · American Journal of Hematology
  21. Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice
    Nathan Eaton, Emily K. Boyd, Ratnashree Biswas, Melissa M. Lee‐Sundlov, Theresa A. Dlugi, Haley Elizabeth Ramsey, Shikan Zheng, Robert T. Burns, Martha C. Sola-Visner, Karin M. Hoffmeister et al. · 2022 · Frontiers in Oncology
  22. Cellular and animal models for the investigation of β-thalassemia
    Antonella Nai, Celia Cordero-Sánchez, Emanuele Tanzi, Alessia Pagani, Laura Silvestri, Simona Maria Di Modica · 2023 · Blood Cells Molecules and Diseases
  23. High-iron consumption decreases copper accumulation and colon length, and alters serum lipids
    Jisu Lee, Hyun‐Joo Lee, Hyunsoo Jang, Jae‐Joon Lee, Jung‐Heun Ha · 2024 · Applied Biological Chemistry
  24. Prise en charge actuelle des thalassémies intermédiaires
    Isabelle Thuret · 2014 · Transfusion Clinique et Biologique
  25. Erythroferrone: the missing link in β-thalassemia?
    Ivan Cruz Moura, Olivier Hermine · 2015 · Blood
  26. The α1‐adrenergic receptor is involved in hepcidin upregulation induced by adrenaline and norepinephrine via the STAT3 pathway
    Wei‐Na Kong, Yanmei Cui, Yujian Fu, Yuhua Lei, Yunzhe Ci, Yongping Bao, Shuqiang Zhao, Lide Xie, Yan‐Zhong Chang, Shu‐E Zhao · 2018 · Journal of Cellular Biochemistry
  27. Liver Iron Retention Estimated from Utilization of Oral and Intravenous Radioiron in Various Anemias and Hemochromatosis in Humans
    Annelies J. van Vuren, Richard van Wijk, Eduard Johannes van Beers, Joannes J.M. Marx · 2020 · International Journal of Molecular Sciences
  28. Iron Through the Prism of Haematology
    John B. Porter · 2020 · British Journal of Haematology
  29. The Role of Erythroferrone Hormone as Erythroid Regulator of Hepcidin and Iron Metabolism during Thalassemia and in Iron Deficiency Anemia- A Short Review
    Tiba Sabah Talawy, Abd Elgadir A. Altoum, Asaad M. A. Babker · 2020 · Journal of Pharmaceutical Research International
  30. Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone
    Laura E. Diepeveen, Rian Roelofs, Nicolai I. Grebenchtchikov, Rachel P. L. van Swelm, Léon Kautz, Dorine W. Swinkels · 2021 · PLoS ONE
  31. Current status of iron metabolism: Clinical and therapeutic implications
    Susana Conde Diez, Ricardo de las Cuevas Allende, Eulogio Conde García · 2017 · Medicina Clínica (English Edition)
  32. Functional erythropoietin‐hepcidin axis in recombinant human erythropoietin independent haemodialysis patients
    Maxime Touzot, Thibaud Lefèbvre, Arthur Roux, Catherine Maheas, Christophe Ridel, Hervé Puy, Zoubida Karim · 2018 · Nephrology
  33. Single‐cell profiling of ineffective erythropoiesis in a mouse model of β‐thalassaemia intermedia
    Yuanliang Peng, Long Liang, Haihang Zhang, Hong Liu, Guanxiong Zhang, Shuming Sun, Xianfeng Guo, Yanpeng Wang, Bin Hu, Rui Liu et al. · 2023 · British Journal of Haematology
  34. Iron trapping in macrophages reshapes the homeostasis of the haematopoietic system
    Laura Crisafulli, Margherita Correnti, Elena Gammella, Elisa D. Camilli, Matteo Brindisi, Eleonora Palagano, Chiara Milanesi, Gabriele Todisco, Matteo Giovanni Della Porta, Cristina Sobacchi et al. · 2025 · British Journal of Haematology
  35. A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humans
    Heinrich Emil Lob, Nikhil Singh, Kusha A Mohammadi, Larisa Ivanova, Beth Crowell, Hyon Jong Kim, Leah Kravets, Nanditha Das, Yonaton Ray, Jee Hae Kim et al. · 2025 · JCI Insight
  36. Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis
    Marina Kremyanskaya, Yelena Z. Ginzburg, Ronald Hoffman · 2025 · Blood
  37. Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis
    Sara El Hoss, Maria A. Lizarralde-Iragorri, Thiago Trovati Maciel, Olivier Hermine · 2026 · HemaSphere
  38. Thalassaemia
    Frédéric B. Piel, Mariane de Montalembert, Reena Das, Kevin H.M. Kuo, Ali T. Taher, Khaled M. Musallam, Marsha J. Treadwell, Suthat Fucharoen, Michael Angastiniotis, Douglas R. Higgs et al. · 2026 · Nature Reviews Disease Primers
  39. Intestinal iron absorption is appropriately modulated to match physiological demand for iron in wild-type and iron-loaded Hamp (hepcidin) knockout rats during acute colitis
    Shireen RL Flores, Savannah Nelson, Regina R. Woloshun, Xiaoyu Wang, Jung‐Heun Ha, Jennifer K. Lee, Yang Yu, Didier Merlin, James F. Collins · 2021 · PLoS ONE
  40. NOVEL IRON BIOMARKERS IN CHRONIC KIDNEY DISEASE
    Agnieszka Zapora-Kurel, Jolanta Małyszko · 2021 · Wiadomości Lekarskie
  41. Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload
    Alia Mohammed Saeed, Neven Nabil, Walaa Ali Elsalakawy, Riham Metwali, Ahmed Khattab, Mary Gamal Naguib · 2021 · The Egyptian Journal of Haematology
  42. Ironing out the role of hepcidin in infection
    Josef T. Prchal · 2017 · Blood
  43. Pathogenetic aspects of hepcidin metabolism and ferrocinetics dysregulation in carbohydrate metabolism disorders
    Т. В. Саприна, Anastasia P. Zima, Н. Н. Мусина, Tatiana S. Prokhorenko, A. V. Latypova, N. S. Shakhmanova, Svetlana V. Budeeva · 2019 · Diabetes Mellitus
  44. The secreted BMP antagonist ERFE is required for the development of a functional circulatory system in Xenopus
    Juliane Melchert, Kristine A. Henningfeld, Sven Richts, Thomas Lingner, Danny David Jonigk, Tomas Pieler · 2019 · Developmental Biology
  45. Hepcidin: looking back at two decades of progress
    Tomas Ganz · 2022 · Nature Cardiovascular Research
  46. Dynamics of Erythroferrone Response to Erythropoietin in Rats
    Peng Xu, Raymond S. M. Wong, Wojciech Krzyżański, Xiaoyu Yan · 2022 · Frontiers in Pharmacology
  47. Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model
    Núria Fàbregas Bregolat, Maja Ruetten, Milene Costa Da Silva, Mostafa A. Aboouf, Hyrije Ademi, Nadine von Büren, Julia Armbruster, Martina Stirn, Sandro Altamura, Oriana Marques et al. · 2022 · Haematologica
  48. Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19
    Joe N. Frost, Fergus Hamilton, David Arnold, Karen T Elvers, Akshay Shah, Andrew E. Armitage, Alice Milne, Jorgen McKernon, Marie Attwood, Yi‐Ling Chen et al. · 2022 · Wellcome Open Research
  49. Diagnostic et traitement d’une surcharge en fer
    M. Ruivard, Hervé Lobbes · 2023 · La Revue de Médecine Interne
  50. Relationship between bone marrow iron load and liver iron concentration in dialysis-associated haemosiderosis
    Guy Rostoker, Manon Dekeyser, Sérgio Francisco, Christelle Loridon, Mireille Griuncelli, Eva Languille-Llitjos, Ghada Boulahia, Yves Cohen · 2023 · EBioMedicine
  51. A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression
    Hiroshi Kawabata, Tatsuki Uchiyama, Soichiro Sakamoto, Junya Kanda, Shinya Oishi, Nobutaka Fujii, Naohisa Tomosugi, Norimitsu Kadowaki, Akifumi Takaori‐Kondo · 2015 · Experimental Hematology
  52. L’érythroferrone, un régulateur érythroïde du métabolisme du fer
    Léon Kautz · 2014 · médecine/sciences
  53. Iron clad: iron homeostasis and the diagnosis of hereditary iron overload
    Matthew M. Heeney · 2014 · Hematology
  54. Soluble hemojuvelin in transfused and untransfused thalassaemic subjects
    Elisa Ferro, Angela Di Pietro, Giuseppa Visalli, Basilia Piraino, Carmelo Damiano Salpietro, Maria Angela La Rosa · 2016 · European Journal Of Haematology
  55. Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8
    Supranee Upanan, Andrew Tristan McKie, Gladys Oluyemisi Latunde-Dada, Sittiruk Roytrakul, Chairat Uthaipibull, Peraphan Pothacharoen, Prachya Kongtawelert, Suthat Fucharoen, Somdet Srichairatanakool · 2017 · International Journal of Hematology
  56. Androgen Therapy for Hypogonadism in Men with Chronic Illnesses
    Wenyi Zhang, Moizza Shabbir, Peter Y. Liu · 2017 · Springer eBooks
  57. L'acéruléoplasminémie héréditaire, une pathologie à ne pas méconnaître
    Hervé Lobbes, Quitterie Reynaud, Sabine Mainbourg, J.-C. Lega, I. Durieu, Stéphane Durupt · 2020 · La Revue de Médecine Interne
  58. Liver Disease in Iron Overload
    Maha M. Guindi · 2018 · Elsevier eBooks
  59. Mendelian inheritance of anemia due to disturbed iron homeostasis
    Clara Camaschella, Alessia Pagani · 2021 · Seminars in Hematology
  60. Megaloblastic anemia-related iron overload and erythroid regulators: a case report
    Nicolas Vallet, Jean-Baptiste Delaye, Martine Ropert, Amélie Foucault, Noémie Ravalet, Sophie Deriaz, Thomas Chalopin, Hélène Blasco, F. Maillot, Olivier Hérault et al. · 2021 · Journal of Medical Case Reports
  61. Genome-wide identification of antisense lncRNAs and their association with susceptibility to Flavobacterium psychrophilum in rainbow trout
    Ali Ali, Mohamed Salem · 2022 · Frontiers in Immunology
  62. Iron Deficiency Anemia
    Sachith Mettananda, Arjuna Salinda Athapathu · 2023 · Elsevier eBooks
  63. Interaction between Erythropoiesis and Iron Metabolism in Human β-thalassemia - Recent Advances and New Therapeutic Approaches
    Nadia Maria Sposi · 2015 · InTech eBooks
  64. Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology
    Driton Vela · 2018 · BioFactors
  65. Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic
    Fabiana Busti, Giacomo Marchi, Alice Vianello, Domenico Girelli · 2020 · Internal and Emergency Medicine
  66. Erythrocyte production and destruction
    Michelle Butina · 2020 · Elsevier eBooks
  67. Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2
    Betty Berezovsky, Martin Báječný, Jana Frýdlová, Iuliia Gurieva, Daniel W. Rogalsky, P. Přikryl, Vít Pospíšil, E Nečas, Martin Vokurka, Jan Krijt · 2021 · International Journal of Molecular Sciences
  68. Ironing out an approach to alleviate the hypoferremia of acute inflammation
    Karin E. Finberg · 2021 · Haematologica
  69. A Decrease in Maternal Iron Levels Is the Predominant Factor Suppressing Hepcidin during Pregnancy in Mice
    Sheridan L. Helman, Sarah J. Wilkins, Jennifer C. J. Chan, Günter Härtel, Daniel F. Wallace, Gregory Jon Anderson, David Michael Frazer · 2023 · International Journal of Molecular Sciences
  70. The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review
    Yousuf Abdulkarim Waheed, Jie Liu, Shifaa Almayahe, Dong Sun · 2024 · Frontiers in Nephrology
  71. Patterns of hemolysis, erythropoiesis, and iron distribution define unique disease trajectories in three mouse models of genetic anemia
    Irina L. Dubach, Raphael M. Buzzi, Dominik J. Schaer, Florence Vallelian · 2025 · Experimental Hematology
  72. Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease
    Brian A. Czaya, Joseph D. Olivera, Moya Zhang, Amber Lundin, Christian D. Castro, Grace Jung, Mark R. Hanudel, Elizabeta Nemeth, Tomas Ganz · 2025 · JCI Insight
  73. Three Novel Spectrin Variants in Jaundiced Neonates
    Robert D. Christensen, Archana M. Agarwal, Hassan M. Yaish, Noel Scott Reading, Elizabeth A. O’Brien, Josef T. Prchal · 2017 · Clinical Pediatrics
  74. Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis
    Dan‐dan Ruan, Yu‐Mian Gan, Tao Lü, Xiao Min Yang, Yao‐Bin Zhu, Qinghua Yu, Lisheng Liao, Ning Lin, Xin Qian, Jie-wei Luo et al. · 2020 · World Journal of Clinical Cases
  75. Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?
    Henry H. L. Wu, Rajkumar Chinnadurai, Robert James Walker · 2022 · Kidney and Dialysis
  76. A Revised Classification of Primary Iron Overload Syndromes
    Yasuaki Tatsumi, Motoyoshi Yano, Shinya Wakusawa, Hiroaki Miyajima, Tetsuya Ishikawa, Shinsaku Imashuku, Atsuko Takano, Wataru Nihei, Ayako Kato, Koichi Kato et al. · 2024 · Journal of Clinical and Translational Hepatology
  77. Exploring the Impact of Iron Overload on Mitochondrial DNA in β-Thalassemia: A Comprehensive Review
    Jyothi M. Narahari, Prajwal Guruswamy, Navyashree Mugur Jagadeesha, Kusuma K. Shivashakar, Divya P. Kumar, Prashanth S. Narayana, Prashant M. Vishwanath, Akila Prashant · 2024 · Gene Expression
  78. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice
    Emanuele Tanzi, Simona Maria Di Modica, Jessica Bordini, Violante Olivari, Alessia Pagani, Valeria Furiosi, Laura Silvestri, Alessandro Campanella, Antonella Nai · 2024 · American Journal of Hematology
  79. Hereditary disorders of ineffective erythropoiesis
    Richard A. King, Rami N. Khoriaty · 2025 · Blood Cells Molecules and Diseases
  80. Influence of "live high-train low" on hemoglobin mass and post-exercise hepcidin response in female endurance athletes
    Titta Kuorelahti, Johanna Kaarina Ihalainen, Vesa Linnamo, Claire Evelyn Badenhorst, Oona Kettunen, Ritva S. Taipale · 2025 · European Journal of Applied Physiology
  81. Potential role of hypobaric hypoxia environment in treating pan-cancer
    Shixuan Zhang, Xiaoxi Hu, Mengzhen Sun, Xinrui Chen, Shiguan Le, Xilu Wang, Jiucun Wang, Zixin Hu · 2025 · Scientific Reports
  82. Anemia in the Surgical ICU
    Aryeh Shander, Lena M. Napolitano, Margit Kaufman · 2016 · Springer eBooks
  83. Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate
    Farhan Shahzad Imran, Pradyumna D. Phatak · 2016 · Expert Review of Hematology
  84. Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts
    Janejira Jaratsittisin, Wannapa Sornjai, Saovaros Svasti, Suthat Fucharoen, Sittiruk Roytrakul, Duncan Richard Smith · 2017 · Hematology
  85. Disorders of Iron Overload
    Antonello Pietrangelo, Michael S Torbenson · 2017 · Elsevier eBooks
  86. Iron Metabolism and Oxidative Status in Patients with Hb H Disease
    Xi Yao, Lu‐Hong Xu, Hong‐Gui Xu, Xinyu Li, Yong Liu, Jianpei Fang · 2019 · Hemoglobin
  87. Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload
    Soumitra Tole, Ali Amid, Jillian Margaret Baker, Kevin H.M. Kuo, Jakob Pugi, Manuel D Carcao · 2019 · Acta Haematologica
  88. Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients
    Federica Pilo, Giovanni Caocci, Giannalisa Mele, Giorgio La Nasa · 2020 · Acta Haematologica
  89. Iron Metabolism and Related Disorders
    Yelena Z. Ginzburg, Karin E. Finberg · 2021 · Elsevier eBooks
  90. [Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].
    X Liu, Jing Ying Hu, Xiaofei Hu, X X Li, Dongwei Guan, J Q Liu, Y L Zhang, F K Zhang · 2021 · PubMed Central
  91. Iron
    Milton Tenenbein, Xi Huang · 2022 · Elsevier eBooks
  92. Iron metabolism abnormalities in autoimmune hemolytic anemia and Jianpishengxue keli can ameliorate hemolysis and improve iron metabolism in AIHA mouse models
    Manjun Zhao, Yan Wang, Jin Yang, Yi Wang, Yingying Feng, Lei Chen, Zonghong Shao, Huaquan Wang, Limin Xing · 2022 · Annals of Medicine
  93. Fetal Factors Disrupt Placental and Maternal Iron Homeostasis in Murine β-Thalassemia
    Yu Yang, Regina R. Woloshun, Jennifer K. Lee, Pearl Onuwa Ebea, Sean Zhu, Elizabeta Nemeth, Laura M. Garrick, Michael D. Garrick, James F. Collins · 2023 · Blood
  94. Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen‐sensing pathway from primary familial and congenital polycythaemia
    Lucie Sochorcova, Katarina Kapralova, Jana Kučerová, Dagmar Pospı́šilová, Daniela Procházková, Ondřej Jahoda, Simona Kureková, Barbora Králová, Martina Divoká, Jana Navrátilová et al. · 2023 · British Journal of Haematology
  95. Hepcidin: SNP-Like Polymorphisms Present in Iron Metabolism and Clinical Complications of Iron Accumulation and Deficiency
    Cadiele Oliana Reichert, Joel da Cunha, Débora Levy, Luciana Morganti Ferreira Maselli, Sérgio Paulo Bydlowski, Celso Spada · 2017 · InTech eBooks
  96. Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients
    Blair Limm-Chan, Katherine Wesseling‐Perry, Meghan H. Pearl, Grace Jung, Eileen Tsai Chambers, Patricia L. Weng, Mark R. Hanudel · 2021 · Pediatric Nephrology
  97. Anaemia of Chronic Kidney Disease: What We Know Now
    Anoushka Krishnan, Debbie Trinder, Anita C. G. Chua, Aron Chakera, Grant A. Ramm, John Kevin Olynyk · 2017 · Journal of Renal and Hepatic Disorders
  98. Métabolisme du fer
    Sophie Vaulont · 2017 · Archives de Pédiatrie
  99. Short-term periods of strenuous physical activity lower iron absorption
    Gary M. Brittenham · 2020 · American Journal of Clinical Nutrition
  100. Oxidative Stress and Hepatic Iron Overload
    Serena Pelusi, Luca V. C. Valenti, Silvia Rossana Fargion · 2015 · Oxidative stress in applied basic research and clinical practice